First Horizon Advisors’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.9K | Sell |
1,591
-849
| -35% | -$7.96K | ﹤0.01% | 1524 |
|
|
2025
Q1 | $17.3K | Sell |
2,440
-493
| -17% | -$3.51K | ﹤0.01% | 1385 |
|
|
2024
Q4 | $34.2K | Buy |
2,933
+259
| +10% | +$3.02K | ﹤0.01% | 1124 |
|
|
2024
Q3 | $55K | Buy |
2,674
+70
| +3% | +$1.44K | ﹤0.01% | 941 |
|
|
2024
Q2 | $58.3K | Buy |
2,604
+472
| +22% | +$10.6K | ﹤0.01% | 856 |
|
|
2024
Q1 | $58.7K | Buy |
2,132
+176
| +9% | +$4.84K | ﹤0.01% | 880 |
|
|
2023
Q4 | $59.6K | Sell |
1,956
-388
| -17% | -$11.8K | ﹤0.01% | 842 |
|
|
2023
Q3 | $74.1K | Sell |
2,344
-806
| -26% | -$25.5K | ﹤0.01% | 709 |
|
|
2023
Q2 | $128K | Sell |
3,150
-200
| -6% | -$8.16K | ﹤0.01% | 578 |
|
|
2023
Q1 | $125K | Sell |
3,350
-5
| -0.1% | -$186 | ﹤0.01% | 587 |
|
|
2022
Q4 | $117K | Buy |
3,355
+80
| +2% | +$2.79K | ﹤0.01% | 576 |
|
|
2022
Q3 | $183K | Sell |
3,275
-236
| -7% | -$13.2K | 0.01% | 456 |
|
|
2022
Q2 | $181K | Buy |
+3,511
| New | +$181K | 0.01% | 484 |
|
|
2022
Q1 | – | Sell |
-1,327
| Closed | -$155K | – | 2102 |
|
|
2021
Q4 | $155K | Buy |
1,327
+106
| +9% | +$12.4K | ﹤0.01% | 557 |
|
|
2021
Q3 | $163K | Buy |
1,221
+224
| +22% | +$29.9K | 0.01% | 546 |
|
|
2021
Q2 | $160K | Sell |
997
-22
| -2% | -$3.53K | 0.01% | 437 |
|
|
2021
Q1 | $81K | Buy |
+1,019
| New | +$81K | ﹤0.01% | 569 |
|